Liquid Biopsy Predicts Outcomes in Resected Pancreatic Cancer
In resected pancreatic ductal adenocarcinoma (PDAC), preoperative circulating tumor DNA (ctDNA) positivity is a strong predictor of poor overall and recurrence-free survival.
Newsletter
Every new paper in this field, in your inbox.
In resected pancreatic ductal adenocarcinoma (PDAC), preoperative circulating tumor DNA (ctDNA) positivity is a strong predictor of poor overall and recurrence-free survival.
An increased area deprivation index (ADI) correlates with a higher risk of 90-day mortality after major hepatectomy, particularly due to posthepatectomy liver failure.
Rural residency correlates with lower treatment rates and worse outcomes for colorectal liver metastases (CRLM).
Detecting circulating tumor DNA (ctDNA) in patients with localized pancreatic ductal adenocarcinoma (PDAC) can help predict outcomes and guide surgical decision-making.
Microscopically positive margins (R1) after colorectal liver metastasis resection indicate worse outcomes but require context for interpretation regarding recurrence and repeat surgeries.
A study found that fibrosis scores significantly differ among pancreatic surgery patients with and without chronic pancreatitis (CP), suggesting that reliance on fibrosis for diagnosis may lead to overdiagnosis of CP.
Adding radiotherapy to neoadjuvant chemotherapy for resectable pancreatic ductal adenocarcinoma improved pathologic response rates but failed to enhance overall or event-free survival.
A new set of dual nomograms can effectively predict overall survival and recurrence risk following pancreatic resection for ductal adenocarcinoma, aiding surgical decision-making and postoperative management.
Patients with chronic liver disease (CLD) present with cholangiocarcinoma (CCA) at earlier stages and experience improved survival rates compared to non-CLD patients.
The left posterior approach to the superior mesenteric artery during robotic pancreaticoduodenectomy offers excellent outcomes, including a high rate of R0 resection and manageable complication rates.